The University of Southampton
University of Southampton Institutional Repository

Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10

Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10
Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10

BACKGROUND: Evidence suggests that a raised level of cord serum IgE (CS-IgE) is a risk factor for allergic sensitisation. However, whether CS-IgE is a risk for asthma is controversial. A study was undertaken to investigate the association between CS-IgE levels and allergic sensitisation at 4 and 10 years of age and asthma at ages 1-2, 4 and 10.

METHODS: CS-IgE was available for 1358 of 1456 children born between 1989 and 1990. The cohort was evaluated for allergic diseases at ages 1, 2, 4 and 10 years. Skin prick tests for six allergens were performed on 981 children at age 4 and 1036 at age 10. Asthma was defined based on a physician's diagnosis. Using logistic regression analysis, the risk of asthma and allergic sensitisation for raised levels of CS-IgE (> or =0.5 kU/l) was estimated.

RESULTS: At ages 4 and 10 years 20.2% and 27.0% of children, respectively, had allergic sensitisation. The risk of allergic sensitisation was significantly associated with raised CS-IgE levels at ages 4 (OR 2.29) and 10 years (OR 1.73). The prevalence of asthma was 10.3% at age 1-2, 15.2% at age 4, and 12.8% at age 10. CS-IgE was not associated with asthma at age 1-2 and 4 but showed an increased relative risk at age 10 (OR 1.66, 95% CI 1.05 to 2.62). The association was stronger in children who did not develop allergic sensitisation at age 4 or 10 (OR 3.35, 95% CI 1.41 to 7.93).

CONCLUSIONS: Raised cord serum IgE is a risk factor for allergic sensitisation at ages 4 and 10 years. This is the second study suggesting that CS-IgE is also a risk factor for asthma at age 10, probably related to the late onset of asthma. This association is not necessarily mediated by allergic sensitisation.

Asthma/blood, Child, Child, Preschool, Female, Fetal Blood/chemistry, Humans, Hypersensitivity/blood, Immunoglobulin E/blood, Male, Risk Factors, Skin Tests
0040-6376
936-42
Sadeghnejad, A.
0bfc6d30-ecd3-405b-8dc9-7d2532496326
Karmaus, W.
2fb26f2a-c8ef-468a-9688-b4c25c19f284
Davis, S.
59eccbaf-0d14-455d-9554-9ec00b6ee4cd
Kurukulaaratchy, R. J.
9c7b8105-2892-49f2-8775-54d4961e3e74
Arshad, S. H.
917e246d-2e60-472f-8d30-94b01ef28958
Sadeghnejad, A.
0bfc6d30-ecd3-405b-8dc9-7d2532496326
Karmaus, W.
2fb26f2a-c8ef-468a-9688-b4c25c19f284
Davis, S.
59eccbaf-0d14-455d-9554-9ec00b6ee4cd
Kurukulaaratchy, R. J.
9c7b8105-2892-49f2-8775-54d4961e3e74
Arshad, S. H.
917e246d-2e60-472f-8d30-94b01ef28958

Sadeghnejad, A., Karmaus, W., Davis, S., Kurukulaaratchy, R. J. and Arshad, S. H. (2004) Raised cord serum immunoglobulin E increases the risk of allergic sensitisation at ages 4 and 10 and asthma at age 10. Thorax, 59 (11), 936-42. (doi:10.1136/thx.2004.024224).

Record type: Article

Abstract

BACKGROUND: Evidence suggests that a raised level of cord serum IgE (CS-IgE) is a risk factor for allergic sensitisation. However, whether CS-IgE is a risk for asthma is controversial. A study was undertaken to investigate the association between CS-IgE levels and allergic sensitisation at 4 and 10 years of age and asthma at ages 1-2, 4 and 10.

METHODS: CS-IgE was available for 1358 of 1456 children born between 1989 and 1990. The cohort was evaluated for allergic diseases at ages 1, 2, 4 and 10 years. Skin prick tests for six allergens were performed on 981 children at age 4 and 1036 at age 10. Asthma was defined based on a physician's diagnosis. Using logistic regression analysis, the risk of asthma and allergic sensitisation for raised levels of CS-IgE (> or =0.5 kU/l) was estimated.

RESULTS: At ages 4 and 10 years 20.2% and 27.0% of children, respectively, had allergic sensitisation. The risk of allergic sensitisation was significantly associated with raised CS-IgE levels at ages 4 (OR 2.29) and 10 years (OR 1.73). The prevalence of asthma was 10.3% at age 1-2, 15.2% at age 4, and 12.8% at age 10. CS-IgE was not associated with asthma at age 1-2 and 4 but showed an increased relative risk at age 10 (OR 1.66, 95% CI 1.05 to 2.62). The association was stronger in children who did not develop allergic sensitisation at age 4 or 10 (OR 3.35, 95% CI 1.41 to 7.93).

CONCLUSIONS: Raised cord serum IgE is a risk factor for allergic sensitisation at ages 4 and 10 years. This is the second study suggesting that CS-IgE is also a risk factor for asthma at age 10, probably related to the late onset of asthma. This association is not necessarily mediated by allergic sensitisation.

This record has no associated files available for download.

More information

Accepted/In Press date: 24 August 2004
Published date: 29 October 2004
Keywords: Asthma/blood, Child, Child, Preschool, Female, Fetal Blood/chemistry, Humans, Hypersensitivity/blood, Immunoglobulin E/blood, Male, Risk Factors, Skin Tests

Identifiers

Local EPrints ID: 446465
URI: http://eprints.soton.ac.uk/id/eprint/446465
ISSN: 0040-6376
PURE UUID: a9a103cb-9b3c-4b4c-9db0-972cc6f56aee
ORCID for R. J. Kurukulaaratchy: ORCID iD orcid.org/0000-0002-1588-2400

Catalogue record

Date deposited: 10 Feb 2021 17:35
Last modified: 17 Mar 2024 02:49

Export record

Altmetrics

Contributors

Author: A. Sadeghnejad
Author: W. Karmaus
Author: S. Davis
Author: S. H. Arshad

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×